SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genes
Ken Tajima(Harvard University), Shyamala Maheswaran(Massachusetts General Hospital), Sarah Javaid(Harvard University), Molly Hammell(Cold Spring Harbor Laboratory), Amanda Engstrom(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Toshifumi Yae(Juntendo University Nerima Hospital), Oliver H. Tam(Neurosciences Institute), Ben S. Wittner(Broad Institute), Joshua C. Black(Australian National University), Johnathan R. Whetstine(Harvard University), Valentine Comaills(Harvard University), Mingzhu Liu(Kunming Medical University), Fumiyuki Takahashi(Juntendo University), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), Robert Morris(Massachusetts General Hospital)
Cited by 58
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k